Edwards Names Theodora (“Doretta”) Mistras as CFO

Edwards Lifesciences announced that Theodora (“Doretta”) Mistras was appointed as its corporate vice president and chief financial officer (CFO), effective at the end of May.

Mistras will succeed Scott Ullem, who revealed in October that he was planning to transition from the role. She joins Edwards from Viatris, where she’s served as CFO since March 2024, leading the company’s global finance organization and overseeing financial planning, reporting, and operation finance.

Before Viatris, Mistras was a managing director in healthcare investment banking at Citigroup Global Markets. Earlier in her career, she held senior leadership roles in healthcare investment banking at Goldman Sachs.

“We are very pleased to welcome Doretta to Edwards as our next CFO,” said Bernard Zovighian, Edwards’ CEO. “Doretta’s broad experience will be instrumental as we execute our differentiated strategy. We look forward to her leadership as we continue to invest in innovation, and also deliver distinguished and durable financial results and long-term value to patients, customers, shareholders and the broader healthcare ecosystem.”

Ullem has served as Edwards’ CEO since 2014.

“We would like to once again thank Scott for his outstanding leadership, partnership and impact,” Zovighian added. “His commitment to a thoughtful transition and his continued support as a strategic advisor in the months ahead reflects the discipline and continuity that have long defined Edwards’ approach to leadership. We are grateful for Scott’s numerous contributions over the years that have helped to strengthen our company both strategically and financially.”